GI-Cure DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed to manage gastrointestinal disorders effectively. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility by enhancing esophageal and gastric emptying and increasing lower esophageal sphincter pressure, thereby alleviating symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing symptomatic relief and promoting mucosal healing in acid-related conditions. GI-Cure DSR is indicated for the treatment of gastroesophageal reflux disease (GERD), dyspepsia, gastritis, and other acid-peptic disorders where delayed gastric emptying and acid hypersecretion coexist. The combined action of Domperidone and Pantoprazole offers synergistic benefits by improving gastric motility while reducing acid production, thus enhancing patient compliance and therapeutic outcomes. GI-Cure DSR should be used under medical supervision, with caution advised in patients with cardiac arrhythmias, hepatic impairment, or known hypersensitivity to either component. Regular monitoring and adherence to prescribed dosage are essential to minimize potential adverse effects and ensure optimal efficacy.